Effect of hyper protect capsule on viability of probiotics that reach to the large intestines
- Conditions
- /A(healthy adults)
- Registration Number
- JPRN-UMIN000038798
- Lead Sponsor
- Morishita Jintan Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 12
Not provided
(1) Those who underwent open surgery within half a year of the trial start (2) Those who have taken antibiotics for more than one week within half a year of the study start (3) Persons who are allergic to the test food (4) Those who plan to change their lifestyle significantly during the examination period (5) Persons who are chronically prone to diarrhea (meaning stools with mud or watery stools) (6) Patients with a history of significant liver dysfunction, renal dysfunction, or cardiovascular disease that is considered inappropriate for this study (7) A person suspected of having a chronic or acute infection (8) Those who are pregnant or nursing or who may be pregnant (9) Those who participated in other clinical trials within the past 1 month (10) Others who were judged by the study investigator to be inappropriate for this study
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of ingested viable probiotic bacteria that reached to colon. : The fecal number of viable bacteria ingested (Bifidobacterium)
- Secondary Outcome Measures
Name Time Method Analysis on gut microbiota by 16S metagenomic analysis : Evaluation of the abundance of Bifidobacterium spp. in the feces